Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students

Open Forum Infectious Diseases

Volumn 1, Issue 3, 2014, Pages

  Gouma, Sigrid ^a,b   Schurink van't Klooster, Tessa M ^a   de Melker, Hester E ^a   Kerkhof, Jeroen ^a   Smits, Gaby P ^a   Hahné, Susan J M ^a   van Els, Cécile A C M ^a   Boland, Greet J ^c   Vossen, Ann C T M ^d   Goswami, Pulak R ^e   Koopmans, Marion P G ^a,b   van Binnendijk, Rob S ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e GROENE HART HOSPITAL   (Netherlands)

Author keywords

Asymptomatic infection; Attack rates; Correlate of protection; IgG antibodies; MMR vaccination; Mumps virus; Risk factors; Serology

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; ASYMPTOMATIC INFECTION; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HOSPITAL; HUMAN; IMMUNOASSAY; INFECTION CONTROL; MALE; MEASLES; MUMPS; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; RUBELLA; VACCINATION; VIRUS TRANSMISSION;

EID: 84978328155     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofu101     Document Type: Article

References (19)

1. Sane J, Gouma S, Koopmans M, et al. Epidemic of mumps among vaccinated persons, The Netherlands, 2009-2012. Emerg Infect Dis 2014; 20:643-8.
2. Davidkin I, Jokinen S, Broman M, et al. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year followup. J Infect Dis 2008; 197:950-6.
3. Cortese MM, Barskey AE, Tegtmeier GE, et al. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J Infect Dis 2011; 204:1413-22.
4. Kontio M, Jokinen S, Paunio M, et al.Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis 2012; 206:1542-8.
5. Greenland K, Whelan J, Fanoy E, et al. Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010 Vaccine 2012; 30:4676-80.
6. Parker Fiebelkorn A, Rosen JB, Brown C, et al. Environmental factors potentially associated with mumps transmission in yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010. Hum Vaccin Immunother 2013; 9: 189-94.
7. Ceyhan M, Tezer H, Yildirim I. Secondary attack rate of hepatitis A, varicella and mumps in household settings and reliability of family history to detect seronegative children for necessity of vaccination. Scand J Infect Dis 2009; 41:501-6.
8. Dittrich S, Hahne S, van Lier A, et al. Assessment of serological evidence for mumps virus infection in vaccinated children. Vaccine 2011; 29:9271-5.
9. Henle G, Henle W, Wendell KK, et al. Isolation of mumps virus from human beings with induced apparent or inapparent infections. J Exp Med 1948; 88:223-32.
10. Borgmann S, Schwab F, Santibanez S, et al. Mumps virus infection in vaccinated patients can be detected by an increase in specific IgG antibodies to high titres: a retrospective study. Epidemiol Infect 2014; 142:2388-96.
11. van Lier EA, Oomen PJ, Giesbers H, et al. Vaccinatiegraad Rijksvaccinatieprogramma. Nederland: RIVM, 2012.
12. World Helath Organization. Module 16: Mumps. Available at: http://whqlibdoc.who.int/publications/2010/9789241500661_eng.pdf. Accessed 14 July 2014.
13. Smits GP, van Gageldonk PG, Schouls LM, et al. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin Vaccine Immunol 2012; 19:396-400.
14. Tischer A, Andrews N, Kafatos G, et al. Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia. Epidemiol Infect 2007; 135:787-97.
15. Andrews N, Pebody RG, Berbers G, et al. The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 2000; 125:127-41.
16. Smits G, Mollema L, Hahne S, et al. Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. PloS One 2013; 8:e58234.
17. Brockhoff HJ, Mollema L, Sonder GJ, et al. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine 2010; 28:2932-6.
18. Wielders CC, van Binnendijk RS, Snijders BE, et al. Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009. Euro Surveill 2011; 16:19989.
19. Latner DR, McGrew M, Williams NJ, et al. Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method. Clin Vaccine Immunol 2014; 21:286-97.